LBF20207PG46: Difference between revisions
No edit summary |
No edit summary |
||
| Line 11: | Line 11: | ||
|Chemical Synthesis= | |Chemical Synthesis= | ||
|Metabolism= | |Metabolism= | ||
|Biological Activity=8-iso PGF2<FONT FACE="Symbol">a</FONT> is reported to inhibit platelet aggregation induced by U-46619 (1 <FONT FACE="Symbol">m</FONT>M) and I-BOP (0.3 <FONT FACE="Symbol">m</FONT>M) with IC50 of 1.6 <FONT FACE="Symbol">m</FONT>M and 1.8 <FONT FACE="Symbol">m</FONT>M, respectively.[[Reference:Morrow_JD:Minton_TA:Roberts_LJ:2nd:,Prostaglandins,1992,44,155|{{RelationTable/GetFirstAuthor|Reference:Morrow_JD:Minton_TA:Roberts_LJ:2nd:,Prostaglandins,1992,44,155}}]] | |||
}} | }} | ||
{{Lipid/Footer}} | {{Lipid/Footer}} | ||
Revision as of 21:00, 6 January 2010
| LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
| IDs and Links | |
|---|---|
| LipidBank | XPR1788 |
| LipidMaps | - |
| CAS | |
| KEGG | {{{KEGG}}} |
| KNApSAcK | {{{KNApSAcK}}} |
| mol | LBF20207PG46 |
| 8-iso Prostaglandin F_2α | |
|---|---|
| |
| Structural Information | |
| 9a,11a,15S-trihydroxy- (8b) -prosta-5Z,13E-dien-1-oic acid | |
| |
| Formula | C20H34O5 |
| Exact Mass | 354.240624198 |
| Average Mass | 354.48096000000004 |
| SMILES | C(CC[C@H](O)C=C[C@H]([C@@H]1CC=CCCCC(O)=O)[C@@H](C[C@@H]1O)O)CC |
| Physicochemical Information | |
| In normal human urine, 8-iso PGF2a level are about 180-200 pg/mg of creatinine. Morrow_JD et al. | |
| 8-iso PGF2a is reported to inhibit platelet aggregation induced by U-46619 (1 mM) and I-BOP (0.3 mM) with IC50 of 1.6 mM and 1.8 mM, respectively. Morrow_JD et al. | |
| Spectral Information | |
| Mass Spectra | |
| UV Spectra | |
| IR Spectra | |
| NMR Spectra | |
| Other Spectra | |
| Chromatograms | |
| Reported Metabolites, References | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
